Harrow Inc

NASDAQ:HROW   3:14:48 PM EDT
13.25
+0.52 (+4.08%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)468.53M
Current PEN/A
Forward PE N/A
2yr Forward PE 18.4
See more stats
Estimates Current Quarter
Revenue$37.19 Million
Adjusted EPS-$0.19
See more estimates
10-Day MA$11.86
50-Day MA$10.71
200-Day MA$13.70
See more pivots

Harrow Inc Stock, NASDAQ:HROW

102 Woodmont Boulevard, Suite 610, Nashville, Tennessee 37205
United States of America
Phone: +1.615.733.4730
Number of Employees: 315

Description

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.